» Articles » PMID: 19720825

A Bifunctional Intronic Element Regulates the Expression of the Arginine/lysine Transporter Cat-1 Via Mechanisms Involving the Purine-rich Element Binding Protein A (Pur Alpha)

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Sep 2
PMID 19720825
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Expression of the arginine/lysine transporter Cat-1 is highly induced in proliferating and stressed cells via mechanisms that include transcriptional activation. A bifunctional INE (intronic element) within the first intron of the Cat-1 gene was identified and characterized in this study. The INE had high sequence homology to an amino acid response element and was shown to act as a transcriptional enhancer in unstressed cells by binding the transcription factor, purine-rich element binding protein A (Pur alpha). During endoplasmic reticulum stress, binding of Pur alpha to the INE decreased; the element acted as a positive regulator in early stress by binding of the transcription factor ATF4 and as a negative regulator in prolonged stress by binding the stress-induced C/EBP family member, CHOP. We conclude that transcriptional control of the Cat-1 gene is tightly controlled by multiple cis-DNA elements, contributing to regulation of cationic amino acid transport for cell growth and proliferation. In addition, we propose that genes may use stress-response elements such as the INE to support basal expression in the absence of stress.

Citing Articles

Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells.

Dai R, Peng F, Xiao X, Gong X, Jiang Y, Zhang M Oncotarget. 2017; 8(37):60962-60974.

PMID: 28977838 PMC: 5617398. DOI: 10.18632/oncotarget.17631.


Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation.

Ishimura R, Nagy G, Dotu I, Chuang J, Ackerman S Elife. 2016; 5.

PMID: 27085088 PMC: 4917338. DOI: 10.7554/eLife.14295.


Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium.

Guzman-Gutierrez E, Armella A, Toledo F, Pardo F, Leiva A, Sobrevia L Purinergic Signal. 2015; 12(1):175-90.

PMID: 26710791 PMC: 4749529. DOI: 10.1007/s11302-015-9491-2.


Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells.

Gonzalez M, Rojas S, Avila P, Cabrera L, Villalobos R, Palma C PLoS One. 2015; 10(4):e0122398.

PMID: 25875935 PMC: 4397070. DOI: 10.1371/journal.pone.0122398.


Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders.

Usdin K, Hayward B, Kumari D, Lokanga R, Sciascia N, Zhao X Front Genet. 2014; 5:226.

PMID: 25101111 PMC: 4101883. DOI: 10.3389/fgene.2014.00226.


References
1.
Ji J, Tsika G, Rindt H, Schreiber K, McCarthy J, Kelm Jr R . Puralpha and Purbeta collaborate with Sp3 to negatively regulate beta-myosin heavy chain gene expression during skeletal muscle inactivity. Mol Cell Biol. 2006; 27(4):1531-43. PMC: 1800711. DOI: 10.1128/MCB.00629-06. View

2.
Edinger A, Cinalli R, Thompson C . Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression. Dev Cell. 2003; 5(4):571-82. DOI: 10.1016/s1534-5807(03)00291-0. View

3.
Hai T, HARTMAN M . The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene. 2001; 273(1):1-11. DOI: 10.1016/s0378-1119(01)00551-0. View

4.
Bhattacharyya S, Habermacher R, Martine U, Closs E, Filipowicz W . Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell. 2006; 125(6):1111-24. DOI: 10.1016/j.cell.2006.04.031. View

5.
Inoue T, Maeno A, Talbot Jr C, Zeng Y, Yeater D, Leman E . Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells. Prostate. 2009; 69(8):861-73. DOI: 10.1002/pros.20936. View